Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Gastroenterology

• Publication date

  2015-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.gastro.2015.08.031PMID 26385706
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond.

  2015cited by this paper
• Novel therapeutic targets in primary biliary cirrhosis

  2015cited by this paper
• Role of Cholangiocytes in Primary Biliary Cirrhosis

  2014cited by this paper
• Genetics and Epigenetics of Primary Biliary Cirrhosis

  2014cited by this paper
• Increased expression of mitochondrial proteins associated with autophagy in biliary epithelial lesions in primary biliary cirrhosis

  2013cited by this paper
• The immunobiology and pathophysiology of primary biliary cirrhosis.

  2013cited by this paper
• A biliary HCO3− umbrella constitutes a protective mechanism against bile acid‐induced injury in human cholangiocytes

  2012cited by this paper
• Up‐regulation of microRNA 506 leads to decreased Cl−/HCO3− anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis

  2012cited by this paper
• AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Biliary Apotopes and Anti-Mitochondrial Antibodies Activate Innate Immune Responses in Primary Biliary Cirrhosis

  2010cited by this paper
• The biliary HCO3− umbrella: A unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies

  2010cited by this paper
• EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

  2009cited by this paper
• The causes of primary biliary cirrhosis: Convenient and inconvenient truths

  2007cited by this paper
• Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis.

  2001cited by this paper
• Primary biliary cirrhosis

  1998cited by this paper
• PRIMARY BILIARY CIRRHOSIS. CHRONIC NON-SUPPURATIVE DESTRUCTIVE CHOLANGITIS.

  1965cited by this paper
• Primary billiary cirrhosis (chronic intrahepatic obstructive jaundice).

  1959cited by this paper
• Primary biliary cirrhosis.

  1950cited by this paper
• Xanthomatous biliary cirrhosis; a clinical syndrome.

  1949cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Primary Biliary Cirrhosis

  year unknowncited by this paper

• Clinical management of autoimmune liver diseases: juncture, opportunities, and challenges ahead

  2025cites this paper
• Efficacy and Safety of Novel Oral Anti-Cholestatic Agents for Primary Biliary Cholangitis: Meta-Analyses and Systematic Review

  2025cites this paper
• Risk of Coronary Artery Disease in Patients with Liver Cirrhosis: A Systematic Review and Meta-analysis

  2024cites this paper
• Review of Current and Upcoming Second-Line Treatments for Primary Biliary Cholangitis

  2024cites this paper
• Letter to editor: NAFLD - there ain't no such thing as a free lunch.

  2024cites this paper
• Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?

  2024cites this paper
• The latest research trends in primary biliary cholangitis: a bibliometric analysis

  2022cites this paper
• Primary Biliary Cholangitis

  2022cites this paper
• Gender-specific development of experimental autoimmune cholangitis induced by double-stranded RNA.

  2021cites this paper
• Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy‐proven nonalcoholic fatty liver disease subjects

  2021cites this paper
• Fibrotic Events in the Progression of Cholestatic Liver Disease

  2021cites this paper
• Current understanding of primary biliary cholangitis

  2020cites this paper
• Primary biliary cholangitis.

  2020cites this paper
• Primary biliary cholangitis

  2020cites this paper
• TianJiu therapy for α-naphthyl isothiocyanate-induced intrahepatic cholestasis in rats treated with fresh Ranunculus sceleratus L.

  2020cites this paper
• Primary Biliary Cholangitis

  2020cites this paper
• MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease.

  2020cites this paper
• Non-neoplastic cholangiopathies: an algorithmic approach

  2020cites this paper
• Identification of clinical risk factors for histological progression of primary biliary cholangitis

  2019cites this paper
• A Practical Review of Primary Biliary Cholangitis for the Gastroenterologist.

  2019cites this paper
• UPDATE OF THE BRAZILIAN SOCIETY OF HEPATOLOGY RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF AUTOIMMUNE DISEASES OF THE LIVER.

  2019cites this paper
• Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus.

  2019cites this paper
• The genetics of primary biliary cholangitis

  2019cites this paper
• Editorial: liver transplantation for primary biliary cholangitis–the need for timely and more effective treatments

  2019cites this paper
• Primary biliary cholangitis

  2018cites this paper
• Environmental basis of primary biliary cholangitis

  2018cites this paper
• Genetics and epigenetics in the pathogenesis of primary biliary cholangitis

  2018cites this paper
• MicroRNA‐506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation

  2018cites this paper
• Primary biliary cholangitis.

  2018cites this paper
• Primary biliary cholangitis: A tale of epigenetically-induced secretory failure?

  2018cites this paper
• Primary Biliary Cholangitis

  2018cites this paper
• Histopathologic Approach to Cholestatic Diseases of the Liver

  2018cites this paper
• Primary biliary cholangitis and bone disease.

  2018cites this paper
• Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis

  2018cites this paper
• Different effects of ursodeoxycholic acid on intrahepatic cholestasis in acute and recovery stages induced by alpha‐naphthylisothiocyanate in mice

  2018cites this paper
• Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review

  2017cites this paper
• Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study

  2017cites this paper
• Novel Treatment Strategies for Primary Biliary Cholangitis

  2017cites this paper
• Prevalence of Systemic Sclerosis in Primary Biliary Cholangitis Using the New ACR/EULAR Classification Criteria

  2017cites this paper
• Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation.

  2017cites this paper
• Chronic cholestatic liver diseases

  2017cites this paper
• Anti-mitochondrial autoantibodies-milestone or byway to primary biliary cholangitis?

  2017cites this paper
• Obeticholic acid, a selective farnesoid X receptor agonist, regulates bile acid homeostasis in sandwich‐cultured human hepatocytes

  2017cites this paper
• Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis

  2017cites this paper
• Novel strategies and therapeutic options for the management of primary biliary cholangitis

  2017cites this paper
• Primary Biliary Cholangitisa

  2017cites this paper
• The fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitis

  2017cites this paper
• miR-425 regulates inflammatory cytokine production in CD4+ T cells via N-Ras upregulation in primary biliary cholangitis.

  2017cites this paper
• Access to care in rare liver diseases: New challenges and new opportunities.

  2017cites this paper
• Toward precision medicine in primary biliary cholangitis.

  2016cites this paper
• Recent advances in the diagnosis and treatment of primary biliary cholangitis

  2016cites this paper
• A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis

  2016cites this paper
• Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis

  2016cites this paper
• Changing Nomenclature for PBC from “Primary Biliary Cirrhosis” to “Primary Biliary Cholangitis”

  2016cites this paper
• The changing faces of cholangitis

  2016cites this paper
• [Cholestatic liver disease].

  2016cites this paper
• The epigenetics of PBC: The link between genetic susceptibility and environment.

  2016cites this paper
• Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation

  2016cites this paper
• Obeticholic acid for the treatment of primary biliary cirrhosis

  2016cites this paper
• Primary biliary cholangitis, let's try to keep the new nomenclature correct!

  2016cites this paper
• Changing nomenclature for PBC from “primary biliary cirrhosis” to “primary biliary cholangitis”

  2016cites this paper
• Fine-mapping analysis revealed complex pleiotropic effect and tissue-specific regulatory mechanism of TNFSF15 in primary biliary cholangitis, Crohn’s disease and leprosy

  2016cites this paper
• 1 ROLE OF AETIOLOGY IN THE PROGRESSION , REGRESSION , AND PARENCHYMAL REMODELLING OF LIVER DISEASE IMPLICATIONS FOR LIVER BIOPSY INTERPRETATION THE INTERNATIONAL LIVER PATHOLOGY STUDY GROUP

  2016cites this paper
• A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.

  2016cites this paper
• Cholestatische Lebererkrankungen

  2016cites this paper
• ROLE OF AETIOLOGY IN THE PROGRESSION, REGRESSION, AND PARENCHYMAL

  2016cites this paper
• It is time to change primary biliary cirrhosis (PBC): New nomenclature from “cirrhosis“ to “cholangitis”, and upcoming treatment based on unveiling pathology

  2015cites this paper
• Predicting Outcomes of Primary Biliary Cholangitis Using the GLOBE Score.

  2015cites this paper